L. Cruz

Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?

M. Provencio, M. Cruz, M. Llanos, 2012, Clinical and Translational Oncology.

Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after a new induction regimen in intermediate and high-risk follicular lymphoma patients according to the follicular lymphoma international prognostic index (FLIPI): A multicenter, prospective Phase II trial of Spanish Lymphoma Oncology Gr

M. Provencio, M. Cruz, M. Llanos, 2013 .

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

M. Benatar, M. Tosun, M. Kurtoğlu, 2023, The Lancet Neurology.